You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Claims for Patent: 9,566,286


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,566,286
Title:Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Abstract: The present invention relates to a topical spray composition comprising a biologically active vitamin D derivative or analog and a corticosteroid, and its use in the treatment of dermal diseases and conditions.
Inventor(s): Lind; Marianne (Bagsv.ae butted.rd, DK), Rasmussen; Gritt (Virum, DK), Sonne; Mette Rydahl (Brondby Strand, DK), Hansen; Jens (Virum, DK), Petersson; Karsten (Ballerup, DK)
Assignee: LEO PHARMA A/S (Ballerup, DK)
Application Number:14/707,662
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,566,286
Patent Claims: 1. A pressurized container adapted to dispensing a topical composition on an affected skin area, the container including a metal container body comprising a sprayable, storage stable, substantially anhydrous topical composition comprising a therapeutically effective amount of calcipotriol or calcipotriol monohydrate and a therapeutically effective amount of a betamethasone ester, said calcipotriol or calcipotriol monohydrate and betamethasone ester being dissolved in a pharmaceutically acceptable propellant selected from the group consisting of dimethyl ether or a propellant mixture comprising a first propellant selected from the group consisting of dimethyl ether and a second propellant selected from the group consisting of C.sub.3-5 alkanes, hydrofluoroalkanes, hydrochloroalkanes, fluoroalkanes and chlorofluoroalkanes, the composition further comprising a pharmaceutically acceptable lipid carrier solubilized or suspended in said propellant or propellant mixture, and a valve assembly including an actuator for releasing the composition as a spray, wherein the metal container body is lined with a chemically inert coating material selected from the group consisting of a polyimide-polyamide resin, a polyamide and a polyimide.

2. A container according to claim 1 which is composed of the metal container body in which said composition is stored, a dip tube, and the valve assembly comprising a valve cup, a valve body, and the actuator.

3. A container according to claim 2, wherein the container body is composed of a metal selected from the group consisting of stainless steel, tinplate and aluminium or aluminium alloy or anodised aluminium.

4. A container according to claim 3, wherein the container body is composed of aluminium or aluminium alloy.

5. A container according to claim 1, wherein the coating material is a polyimide-polyamide resin.

6. A container according to claim 1 further comprising gaskets or seals of chemically inert materials.

7. A container according to claim 6 comprising gaskets or seals of materials that are impermeable to the propellant or propellant mixture included in said composition.

8. A container according to claim 6, wherein the gaskets or seals are composed of materials selected from the group consisting of fluoroelastomers, fluorinated ethylene-propylene copolymer (FEP), fluororubber (FPM) or ethylene-propylene diene monomer rubber (EPDM).

9. A container according to claim 2, wherein the dip tube is composed of polyethylene or polypropylene.

10. A container according to claim 1, wherein the valve assembly is composed of a valve cup attached to the container body by crimping, a valve body which contains a valve stem and a spring connected to the actuator which is depressed for activation to expel the composition from the container.

11. A container according to claim 10, wherein the valve stem (contains at least one aperture with a diameter of 0.05-1 mm.

12. A container according to claim 10, wherein the actuator is provided with an insert having a terminal orifice with a diameter of 0.3-1.5 mm.

13. A container according to claim 1, wherein the betamethasone ester is betamethasone dipropionate or betamethasone valerate.

14. A container according to claim 1, wherein the second propellant of the propellant mixture is a C.sub.3-5 alkane.

15. A container according to claim 14, wherein the C.sub.3-5 alkane is selected from the group consisting of n-propane, isopropane, n-butane or isobutane.

16. A container according to claim 15, wherein the C.sub.3-5alkane is n-butane or isobutane.

17. A container according to claim 15, wherein the ratio of n-butane or isobutane to dimethyl ether is in the range of 6:1-0:1 v/v.

18. A container according to claim 14, wherein the ratio of n-butane and/or isobutane to dimethyl ether is in the range of 6:1-0:1 v/v.

19. A container according to claim 10, wherein the valve stem is composed of polyamide or acetal (POM).

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.